Second-generation Drug-eluting Stents in Diabetes

Exclusion Criteria

• •Cardiogenic shock or resuscitation
• •Comorbidity with anticipated life expectancy to 24 months
• •Inability to consent due to mechanical ventilation
• •Pregnant female patient
• •Conditions that could preclude a minimal of 1 month of DAPT (such as, but not limited to: severe liver failure, platelet count \<100,000 cells/mm3, recent gastrointestinal bleeding or history of bleeding diathesis or coagulopathy)
• •Contraindication or known allergy to aspirin, heparin, P2Y12 inhibitors, cobalt and/or chromium metal alloys, sirolimus or derivates, polyurethane, or contrast media (for contrast-media allergy, patients that might be safely and adequately pre-medicated should be allowed to enter the study).
• •Currently enrolled in another clinical trial.